Japan Tobacco Inc.

JT aims to be "a company that provides unique and invaluable brands tomeet your needs." In addition to its efforts in the development of global brand within the tobacco business, JT is trying to establish a distinctive, internationally recognized research and development driven pharmaceuticals business. JT has been striving to strengthen its research and development programs to provide high-quality drugs for its customers' health and to develop original medicine that will help to save people around the world and patients will come to rely on the drugs that JT produces. In food operations, JT is aggressively launching new processed foods and beverages to promote JT's brands as the right brands for your loved ones. JT has produced many top selling products and its commodities and services appeal to a diverse range of people. JT is no longer just a tobacco company. Within JT's tri-pillar business operations (tobacco, pharmaceuticals and foods), JT is establishing value-added brands

Contact Details: 2-1, Toranomon 2-chome Minato-ku Tokyo 105-8422 Japan Tel: Fax: Email: WWW: www.jti.co.jp/

Recent Publications by Japan Tobacco Inc.:
Effect of food restriction on adipose tissue in spontaneously diabetic Torii fatty rats. Spontaneously Diabetic Torii-fa/fa (SDT fatty) rat is a new model of obese...	5th November, 2009	Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1-1,	Exp Diabetes Res. 2009;2009:715057. Epub 2009 Aug 19. DOI Direct Link
Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST)...	3rd November, 2009	Toxicology Research Lab., Central Pharmaceutical Research Institute, JAPAN	J Toxicol Sci. 2009 Oct;34(4):377-87.
Analysis of hydrogen peroxide in an aqueous extract of cigarette smoke and effect of pH on the yield. An analysis of hydrogen peroxide in an aqueous extract of cigarette smoke,...	8th October, 2009	Japan Tobacco Inc., Yokohama,	Biosci Biotechnol Biochem. 2009 Oct;73(10):2222-5. Epub 2009 Oct 7.
An {alpha}2,6-sialyltransferase cloned from Photobacterium leiognathi strain JT-SHIZ-119 shows both sialyltransferase and neuraminidase activity. We cloned, expressed, and characterized a novel beta-galactoside...	3rd October, 2009	Glycotechnology Business Unit, Japan Tobacco Inc., 700 Higashibara, Iwata,	Glycobiology. 2009 Sep 30. DOI Direct Link
Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors. A series of 1-sulfonylaminocyclopropanecarboxylates was synthesized as...	22nd September, 2009	Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1,	Bioorg Med Chem Lett. 2009 Nov 1;19(21):6213-7. Epub 2009 Sep 3. DOI Direct Link
→View more Japan Tobacco Inc. research publications.

Press Releases on Japan Tobacco Inc.:
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results	9th November, 2009	Keryx Biopharmaceuticals, Inc.	NEW YORK, Nov. 9 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically

BioNews Results for Japan Tobacco Inc.:
BAT 9-month cigarette sales volume up 2 pct	Research & Development:  Oct 28 2009 8:48AM Matching: japan tobacco inc
Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals	Interest!ALERT:  Oct 15 2009 1:32PM Matching: japan tobacco inc
Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals	World Market Media:  Oct 15 2009 12:55PM Matching: japan tobacco inc
Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals	WaveForm:  Oct 15 2009 11:53AM Matching: japan tobacco inc
Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals	GlobeNewswire via MSN Money:  Oct 15 2009 11:05AM Matching: japan tobacco inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Japan Tobacco Inc. news.

Japan Tobacco Inc. Patents:
US Patent No.	Title
7211572	Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
7285389	Protein, gene encoding the same, and method of utilization thereof
7285551	Fused-ring compounds and use thereof as drugs
7285572	CaSR antagonist
7285618	Polypeptides having neutrophil stimulating activity
→View more Japan Tobacco Inc. patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 55 individuals from Japan Tobacco Inc. using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 538 times since April 2007, the link to the organisation's website has been followed 84 times

Recent Search Terms used to find this page: japan tobacco inc email | japan tobacco inc | japan tobacco company iwata | Japan tobacco email | japan tobacco R D | japan tobacco inc driven brands | n-substituted 2-phenyl-1-sulfonyl amino-cyclopropane | japanese tobacco research and development | japan tobacco inc. email address | Tobacco Science Research Center Japan Tobacco Inc. 6-2 Umegaoka | .

Search for more companies in Minato-ku

Search for more companies in Tokyo

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Japan Tobacco Inc.